Biomerica Inc risk profile
65 Stretched several inputs deteriorating together
Measured 21 October 2026 from BMRA's filed statements. Recomputed nightly.
65 (Stretched), driven by Cash conversion at 100, over 6 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 78 | Stretched | Volatile | One-year price volatility — 58.6% |
| Operating pressure | 41 | Elevated | Stable | Costs outgrowing revenue — +9.7 percentage points |
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -0.00x |
| Leverage and coverage | 84 | Acute | Worsening | Net debt to EBITDA |
| Competitive position | 82 | Acute | Stable | Operating-margin gap against peers — -14.5 percentage points |
| Concentration | 33 | Normal | Stable | Geographic concentration — 2,815 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.